<DOC>
	<DOCNO>NCT02614274</DOCNO>
	<brief_summary>The Nutramax test article nutritional supplement contain several ingredient show potentially provide benefit patient suffer painful sometimes debilitate condition knee call `` osteoarthritis . '' This pilot study intend determine whether result proprietary testing panel conduct blood urine sample correlate data physical examination validate survey measure participant ' quality life physical capability .</brief_summary>
	<brief_title>Nutramax Joint Health Formulation Biochemical Response Study</brief_title>
	<detailed_description>Osteoarthritis ( OA ) knee significant source morbidity , especially patient age 40 associate $ 90 billion US health care cost annually . While myriad clinical intervention available , mainstay OA therapy NSAIDs , class compound well documented side effect include death ; risk increase patient age chronic use . Assessing effectiveness OA treatment modality often complicate high placebo effect , make purely clinical assessment outcomes difficult . It therefore desirable develop objective assessment tool diagnosis/staging knee OA patient response interventional therapy . Participants study receive formulation nutraceutical ( test article ) . They ask take 3 pill per day 40-44 day . There either 4 5 study visit . If participant use certain medication dietary supplement , ask return one week initial screening , make total 5 visit study . If use key medication dietary supplement , study activity begin day initial screen 4 study visit . Participants ask complete series questionnaires health , blood drawn ( 15 mls 3 teaspoon ) , provide urine sample 4 visit . In addition , first visit , collect information participant ' medical record physical exam .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>1 . Subject able understand sign inform consent . 2 . Subject willing able comply protocol . 3 . Male female subject race , age 40 64 year 4 . Subject BMI 24 40 kg/m2 5 . Subject pain one knees minimum 15 day within 30 day prior start study . 6 . Subject symptom knee pain least 6 month . 7 . Subject diagnose within previous 30 day moderate severe knee osteoarthritis base attend physician 's diagnosis physical exam conjunction KellgrenLawrence Xray grade ≥ 2 ( radiograph take within previous 30 day must available investigator , obtain screen visit ) . 8 . Subject walk . 9 . Before study enrollment , subject routinely use acetaminophen ( dose ) history therapeutic benefit . 10 . Subject visual analogue scale ( VAS ) score ≥ 4 initial visit . Subject may continue take acetaminophen screen take additional analgesic least 48 hour prior initial visit . 11 . Female subject abstains sexual intercourse , surgically sterile , postmenopausal , agree use FDAapproved method birth control . 1 . Subject follow medical condition : 1. active heart disease define currently care cardiologist 2. high blood pressure ( ≥ 140/90 mmHg ) 3. renal hepatic impairment/disease 4 . Type I II diabetes 5 . Bipolar major depressive disorder history psychiatric illness require hospitalization past 6 month . 6 . Parkinson 's disease 7. unstable thyroid disease 8. immune disorder ( HIV/AIDS ) 9. multiple sclerosis autoimmune disorder 10. arthritic condition , OA , affect joint knee 11. acute septic arthritis 12. fibromyalgia chronic pain syndrome ( OA location knee allow ) 13. gout hyperuricemia 14. peptic ulcer disease and/or history upper gastrointestinal bleeding 15. medical condition deem exclusionary Principal Investigator ( PI ) 2 . Subject history cancer ( except localize skin cancer without metastasis situ cervical cancer ) within five year prior screen . 3 . Subject significant injury target joint within past 12 month . 4 . Subject plan knee surgery next 2 month . 5 . Subject asthma attack , hive , allergic reaction aspirin NSAID medication . 6 . Subject allergy avocado , soybean , shellfish ingredient test product . 7 . Subject require additional analgesic change acetaminophen . ( Subjects require acetaminophen dose adjustment may remain study dose and/or schedule change shall record raw data daily patient diary ) . 8 . Subject currently take medication suffers medical condition , deem potentially interfere objective study determine PI . 9 . Subject history drug alcohol abuse past 12 month . 10 . Subject currently consume 2 standard alcoholic beverage day . A standard alcoholic beverage define 12 ounce beer , 5 ounce wine , 1.5 ounce liquor . 11 . Subject agree use FDAapproved method birth control pregnant , lactating , plan become pregnant study period . 12 . Subject condition abnormality , opinion investigator , would compromise safety subject quality study data . 13 . Subject participate participate another research study within 30 day prior screen . 14 . Subject use , intend use , oral injectable NSAID ( e.g. , ketorolac , aspirin , ibuprofen , naproxen , diclofenac , etc . ) within 7 day prior screen study completion . 15 . Subject treated oral corticosteroid within 4 week prior screen . 16 . Subject intraarticular corticosteroid target joint within 3 month prior screen . 17 . Subjects may take dietary , vitamin , mineral , herbal supplement within 7 day prior Day 0 study completion . For subject take product time initial visit , sevenday washout period prior study Day 1 allow EXCEPT joint health/antiinflammatory product ( see # 18 ) . 18 . Subjects currently take take ≥ 30 consecutive day OR ≥ 60 day total , within 180 day prior screen , dietary product intend decrease inflammation , body pain and/or improve joint health ; include , necessarily limit , glucosamine , chondroitin , avocadosoybean unsaponifiable ( ASU ) , methylsulfonylmethane ( MSM ) shall exclude study .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>knee</keyword>
	<keyword>pain</keyword>
	<keyword>osteoarthritis</keyword>
	<keyword>nutraceutical</keyword>
	<keyword>nutrition</keyword>
	<keyword>supplement</keyword>
	<keyword>non-surgical</keyword>
	<keyword>biomarker</keyword>
	<keyword>joint health</keyword>
</DOC>